glp 1 isn't working 3 weird reasons your GLP-1 Why is my GLP-1 medication
Description
Sarafidis P, Ferro CJ, Morales E et al

Eli Lilly: Mazdutide/ LY3305577 / Formerly Innovent IBI362 Oxyntomodulin (OXM) is a peptide which acts as a dual GLP1R/GR dual agonist
/assets/images/provider/photos/2813769.png)
We hypothesized that hypoxia might affect nutrient-stimulated GLP-1 levels from the mouse enteroendocrine cell line STC-1 [29]
However, stopping treatment often results in weight regain and return of appetite to pre-treatment levels

Contrary to expectations, glycaemic control was also improved after chronic treatment with the GLP-1R/GcgR co-agonist, which implies that GLP-1 activity protected against glucagon-induced hyperglycaemia [17]

Variants in GLP1R (the GLP-1 receptor itself), GIPR (rs1800437 is the headline variant for differential GLP-1 response), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with measurably different response patterns to semaglutide and tirzepatide
